<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Edalat H</submitter><funding>Basij Elmi Organization</funding><pagination>1187-1194</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11482153</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(7)</volume><pubmed_abstract>Bone marrow stromal cells (BMSCs) are attractive cellular sources for cell therapy of many diseases, specifically neurodegenerative ones. The potential capability of BMSCs could be further augmented by enhancing their neuroprotective property, differentiation potential, and survival rate subsequent to transplantation. Therefore, a concurrent upregulation of neurotrophin-3 (NT-3) and its high affinity receptor, tyrosin kinase C (TrkC), was utilized in our study. BMSCs were cotransfected with pDsRed1-N1-NT-3 and pCMX-TrkC plasmids before induction of neural differentiation. pEGFP-N1-transfected BMSCs were also employed as a control. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was employed for gene expression analysis. Cell viability was evaluated by MTT a</pubmed_abstract><journal>Cellular and molecular neurobiology</journal><pubmed_title>Exogenous Expression of Nt-3 and TrkC Genes in Bone Marrow Stromal Cells Elevated the Survival Rate of the Cells in the Course of Neural Differentiation.</pubmed_title><pmcid>PMC11482153</pmcid><funding_grant_id>3657</funding_grant_id><pubmed_authors>Mowla SJ</pubmed_authors><pubmed_authors>Pirhajati V</pubmed_authors><pubmed_authors>Edalat H</pubmed_authors><pubmed_authors>Tavallaei M</pubmed_authors><pubmed_authors>Hajebrahimi Z</pubmed_authors><pubmed_authors>Movahedin M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exogenous Expression of Nt-3 and TrkC Genes in Bone Marrow Stromal Cells Elevated the Survival Rate of the Cells in the Course of Neural Differentiation.</name><description>Bone marrow stromal cells (BMSCs) are attractive cellular sources for cell therapy of many diseases, specifically neurodegenerative ones. The potential capability of BMSCs could be further augmented by enhancing their neuroprotective property, differentiation potential, and survival rate subsequent to transplantation. Therefore, a concurrent upregulation of neurotrophin-3 (NT-3) and its high affinity receptor, tyrosin kinase C (TrkC), was utilized in our study. BMSCs were cotransfected with pDsRed1-N1-NT-3 and pCMX-TrkC plasmids before induction of neural differentiation. pEGFP-N1-transfected BMSCs were also employed as a control. Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was employed for gene expression analysis. Cell viability was evaluated by MTT a</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Oct</publication><modification>2026-06-02T20:08:30.252Z</modification><creation>2025-04-07T07:53:25.419Z</creation></dates><accession>S-EPMC11482153</accession><cross_references><pubmed>27891557</pubmed><doi>10.1007/s10571-016-0448-y</doi></cross_references></HashMap>